Blood transfusion of transfusing uncrossmatched blood, O-negative blood is used, followed by crossmatch as soon as possible. O-negative is also used for children and women of childbearing age. It is preferable for the laboratory to obtain a pre-transfusion sample in these cases so a type and screen can be performed to determine the actual blood group of the patient and to check for alloantibodies. This chart shows possible matches in blood transfusion between donor and receiver using ABO and Rh system. In the same way that the safety of pharmaceutical products is overseen by pharmacovigilance, the safety of blood and blood products
Jehovah's Witnesses and blood transfusions and other blood-borne infections, or immune system reactions. Many physicians have expressed a willingness to respect patients' preferences and provide bloodless treatment and about 200 hospitals offer bloodless medicine and surgery programs for patients who wish to avoid or limit blood transfusions. Bloodless surgery has been successfully performed in significant procedures including open-heart surgery and total hip replacements. A 2012 study in "JAMA Internal Medicine" concluded that "Witnesses do not appear to be at increased risk for surgical complications or long-term mortality when comparisons are properly made by transfusion status. Thus, current extreme blood management strategies do not appear to